ClinVar Miner

Submissions for variant NM_005159.5(ACTC1):c.1098G>A (p.Glu366=)

gnomAD frequency: 0.00001  dbSNP: rs758173419
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000419163 SCV000511964 likely benign not specified 2015-10-22 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Color Diagnostics, LLC DBA Color Health RCV001187670 SCV001354529 likely benign Cardiomyopathy 2019-08-12 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001437639 SCV001640498 likely benign Hypertrophic cardiomyopathy 11; Dilated cardiomyopathy 1R; Atrial septal defect 5 2021-05-13 criteria provided, single submitter clinical testing
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV001187670 SCV004240302 likely benign Cardiomyopathy 2023-01-10 criteria provided, single submitter clinical testing
All of Us Research Program, National Institutes of Health RCV003995945 SCV004844799 likely benign Hypertrophic cardiomyopathy 2023-03-28 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.